Literature DB >> 7188733

Purification and characterization of human vascular plasminogen activator.

B Aasted.   

Abstract

The vascular tree of the legs of human corpses was perfused with 0.15 M NaCl, and eluted with 2 M KSCN and finally with 0.15 M NaCl. The average total activity of human vascular plasminogen activator and protein eluted per leg was 29 800 Ploug units and 8.3 g respectively. Fibrin-Sepharose adsorbed the plasminogen activator activity, which could be eluted with 2 M KSCN. A small column containing from 0.5--1.9 ml of phenyl-Sepharose, normally coupled directly to the outlet of the fibrin-Sepharose column, adsorbed all the plasminogen activator activity. Elution of this hydrophobic matrix yielded a plasminogen activator preparation 17% pure judging from sodium dodecyl sulphate polyacrylamide gel electrophoresis. By this method human vascular plasminogen activator was found to have an Mr of 60 000. Upon reduction, two bands of Mr 30 000 and 31 000 were estimated. Human vascular plasminogen activator could be inhibited by diisopropylfluorophosphate. Isoelectric focusing yielded four major bands with the isoelectric points of 6.9, 7.4, 8.0 and 8.6. Human vascular plasminogen activator was found to be a relatively stable protein in purified form.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7188733     DOI: 10.1016/0005-2795(80)90176-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Coamplification and coexpression of human tissue-type plasminogen activator and murine dihydrofolate reductase sequences in Chinese hamster ovary cells.

Authors:  R J Kaufman; L C Wasley; A J Spiliotes; S D Gossels; S A Latt; G R Larsen; R M Kay
Journal:  Mol Cell Biol       Date:  1985-07       Impact factor: 4.272

2.  Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex.

Authors:  E G Levin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

3.  Immunological characterisation of plasminogen activators in the human vessel wall.

Authors:  H Ljungnér; L Holmberg; A Kjeldgaard; I M Nilsson; B Astedt
Journal:  J Clin Pathol       Date:  1983-09       Impact factor: 3.411

4.  Isolation from human plasma of a plasminogen activator identical to urinary high molecular weight urokinase.

Authors:  J D Tissot; P Schneider; J Hauert; M Ruegg; E K Kruithof; F Bachmann
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

5.  Urokinase separation from cell culture broth of a human kidney cell line.

Authors:  Vibha Bansal; Pradip K Roychoudhury; Ashok Kumar
Journal:  Int J Biol Sci       Date:  2006-11-22       Impact factor: 6.580

6.  Urinary plasminogen activator activity in progressive renal failure.

Authors:  S Y Hong; D H Yang
Journal:  Korean J Intern Med       Date:  1990-01       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.